#acute myeloid leukemia

The Latest Advancements in Immunotherapy for Adult Leukemia

In her book “Finding a Way,” champion triathlete, horse rescuer and leukemia thriver Siri Lindley gives you tools to triumph.

The FDA approved Vanflyta (quizartinib) with chemotherapy for FLT3-mutated AML, an aggressive type of blood cancer.

Trial showed that treatment with quizartinib led to a significant improvement in overall survival.

When Charlie Huang almost lost the chance at a lifesaving stem cell transplant for his acute myeloid leukemia, he vowed to help others.

Cancer survivors make awesome advocates, and the summer 2023 issue of Cancer Health profiles several inspiring figures.

Marc Franke is part of an exclusive circle of people cured of HIV after a stem cell transplant to treat cancer.

The drug, revumenib, is a menin inhibitor that has led to remission in clinical trials involving acute myeloid leukemia.

The bipartisan deal will make 600,000+ North Carolinians newly eligible for lifesaving care, including cancer screenings and treatment.

Newly FDA-approved drugs for ovarian, bladder, liver cancer, and more.

A small group of adults in remission had persisting mutations that predicted their risk of death from having the cancer return.

For Steve Buechler, terms like “journey” and “battle” fail to describe his experiences with leukemia. Other people with cancer agree.

Meet the eight innovative scientists and learn about the research Damon Runyon is funding.

A team of experts on acute promyelocytic leukemia (APL) were available by phone or email to other oncologists treating this rare cancer.

Immunotherapy leads the way, along with promising breakthroughs for treating leukemia and multiple myeloma.

"This is almost double what was previously estimated,” researchers said of the number of Californians who died of tobacco-related cancers.

The test shows which patients with clonal hematopoiesis, a precancerous state, are more likely to develop blood cancers.